Loading data for AMRX — first visit, this takes a few seconds.

Amneal Pharmaceuticals, Inc.

NasdaqGS: AMRX · Real-Time Price · USD
17.68
+0.21 (1.20%)
At close: Sep 01, 2026, 8:00 PM
17.68
+0.00%
After-hours: 4:20 PM

The price, the headline numbers and the latest news, in one place.

Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, Analysis & Data

No data available

Bid12.68
Market Cap6.16B
Revenue (ttm)3.12B
Net Income (ttm)157M
1.25
0.48
36.83
15.23
P/B (ttm)171.65
P/S (ttm)1.98
Earnings DateMay 4, 2026
Ask22.47
Volume1,353,613
Avg. Volume (20D)1,981,942
Open17.57
Previous Close17.47
Day's Range17.49 - 17.99
52-Week Range9.32 - 19.26
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About AMRX

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and e...

Sector Healthcare
IPO Date May 7, 2018
Employees 8,700
Stock Exchange NasdaqGS
Ticker Symbol AMRX
Full Company Profile

Financial Performance

In 2025, Amneal Pharmaceuticals's revenue was 3.02B, an increase of 8.05% compared to the previous year's 2.79B. Earnings were 72.06M, a decrease of -161.65%.

Financial Statements

Earnings Surprise

Amneal Pharmaceuticals has released their quarterly earnings on Jul 30, 2026:
  • Revenue of $796.2M misses estimates by $0, with 9.89% YoY growth.
  • EPS of 0.3 exceeds estimates by 0.07, with 20.00% YoY growth.
Amneal Pharmaceuticals, Inc. is scheduled to release its earnings on May 4, 2026, after market closes.
Analysts project revenue of ... Upgrade